News and Announcements
Income2Wealth announces $2,681,942 distributions paid in July 2022
- Published September 15, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
The Results Are In & They’re Strutting Their Stuff!
Financial fitness never looked so good!
Our Armchair Investment Managed Funds are kicking off July 2022 financially fit & fabulous with an incredible:
- $151M+ Funds Currently Under Management
- $2,681,942 Distributions Paid in July 2022
- $47M+ in Total Distributions paid since 2018
- 100% Completed Term Capital returned to investors totalling $41M+
If your financial fitness is looking like it has been hibernating on the couch this winter binge-watching Netflix, then what better first step than to put down the remote and get it in shape by investing your personal, business of Self-Managed Superannuation funds into our regulated Managed Fund investments?
With superior returns ranging from 8% – 20% p.a. paid monthly, a choice of investment term lengths and offers starting from an investment amount of $5,000, there’s an option for every financial fitness level.
Call us on 1800 600 890 to find out how we can get your finances in shape and looking fabulous in no time at all (and just quietly, without a lot of sweat & effort!)
Connect with the company and learn more about House of Raglan by accessing their deal room here.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
